Skip to search formSkip to main contentSkip to account menu

NU6102

Known as: O(6)-cyclohexylmethoxy-2-(4'-sulfamoylanilino)purine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Purines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
O 1 Luminescent non-metal probes for the analysis of protein kinases and their inhibitors
Cyclin-dependent kinases (Cdks) are essential for the control of cell cycle transitions, and changes in activity of a single Cdk1… 
2010
2010
Synthesis of sulfonamide-based kinase inhibitors from sulfonates by exploiting the abrogated SN2 reactivity of 2,2,2-trifluoroethoxysulfonates.
The attenuated S(N)2 reactivity of the 2,2,2-trifluoroethyl group has been exploited for the synthesis of a series of 6… 
2009
2009
The kinase inhibitor O 6-cyclohexylmethylguanine ( NU 2058 ) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK 2
O-Cyclohexylmethylguanine (NU2058) was developed as an inhibitor of CDK2 and was previously shown to potentiate cisplatin… 
2008
2008
[abstract] Preclinical in vitro and in vivo evaluation of the cyclin dependent kinase 2 inhibitor NU6102 and a water pro-drug NU6301
2005
2005
Study of a ligand complexed with Cdk2/Cdk4 by computer simulation
AbstractCyclin-dependent kinases (Cdks) play important roles in the regulation of the cell cycle. Their inhibitors have entered… 
2005
2005
Comparative activity of the potent selective CDK2 inhibitor NU6102 in CDK2 wild-type and knock-out mouse embryo fibroblasts
4409 Cyclin-dependent kinases (CDK) regulate cell cycle progression, and CDK deregulation due to cyclin over-expression, mutation… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)